5.32 -0.13 (-2.39%)
ZIOP
| Trade ZIOP now with |
|
Stock Details
Last Trade:5.32 Change:-0.13 (-2.39%) Prev Close:5.45 Open: 5.45 Days Range:5.30 – 5.54 52 Week Range: 3.55 - 7.85 Volume:452930 P/E: N/AEPS:-1.05
View AllRecent Alerts 02/09/12
Recent Alert on 02/06/12 at 6:14am
ZIOPHARM (ZIOP) NDA for Zymafos Accepted by U.S. FDA
ZIOPHARM (ZIOP) NDA for Zymafos Accepted by U.S. FDA
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), reports the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for the oral dosing of palifosfamide (Zymafos or ZIO-201), a form of administration offering... Read More
Recent Alert on 01/30/12 at 6:12am
ZIOPHARM (ZIOP) Gets Nod from IDMC to Continue Palifosfamide PICASSO 3
ZIOPHARM (ZIOP) Gets Nod from IDMC to Continue Palifosfamide PICASSO 3
Recent Alert on 01/30/12 at 6:12am
ZIOPHARM (ZIOP) Gets Nod from IDMC to Continue Palifosfamide PICASSO 3
ZIOPHARM (ZIOP) Gets Nod from IDMC to Continue Palifosfamide PICASSO 3
Recent Alert on 01/20/12 at 9:35am
Pre-Open Movers 1/20: (INSM) (MSFT) (IBM) Higher; (NCIT) (GOOG) (ISRG) Lower (more...)
Pre-Open Movers 1/20: (INSM) (MSFT) (IBM) Higher; (NCIT) (GOOG) (ISRG) Lower (more...)
View AllRecent Press Releases
Press Release on 02/07/12 at 6:10am
ZIOPHARM Oncology to Present at the 14th Annual BIO CEO & Investor Conference
ZIOPHARM Oncology to Present at the 14th Annual BIO CEO & Investor Conference
View AllRecent SEC Filings
SEC Filing on 02/08/12 at 4:10pm
Form SC 13G/A ZIOPHARM ONCOLOGY INC Filed by: Merlin BioMed Private Equity Advisors, L.L.C.
Form SC 13G/A ZIOPHARM ONCOLOGY INC Filed by: Merlin BioMed Private Equity Advisors, L.L.C.